The Bioscience Discovery Evaluation Grant Program (BDEGP) aids in the growth of the bioscience industry in Colorado. The program advances new technnologies from the lab toward commercial products and services, supporting innovation, company formation, and job creation.
Since the program's inception in 2007 through June 2013, the BDEG program successes include the creation of 45 new Colorado companies and the direct creation of approximately 381 jobs. Additionally, these funds have helped the technologies acquire an additional $418 million dollars in grants and investments to further commercialize these bioscience technologies.
The Program Report highlights accomplishments and identifies grants made under the program.
Application for the Proof of Concept and Early-Stage Company Grant programs are below:
Commercialization Infrastructure Rules and Application
The Commercialization Infrastructure grants are intended to support partnership efforts between the bioscience industry and research institutions to build infrastructure that supports the commercialization of therapeutic and diagnostic products, devices or instruments to improve human health; bioscience technologies that improve agriculture; and biofuels. This infrastructure should enhance the commercialization of technologies and support companies that are commercializing Colorado-based technology by providing a statewide bioscience sector specific industrial commons.